Knight Therapeutics Announces Launch of JORNAY PM™ in Canada
MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of JORNAY PM™ (methylphenidate HCI extended-release capsules) in Canada. JORNAY PM™
(Financial Post, 2025-10-30T21:17:23Z)